Megui Marilia Mansilla Gallegos

Megui Marilia Mansilla Gallegos

Auto-generated profile, based on publicly available information

Megui Marilia Mansilla Gallegos

Gastrointestinal Endoscopy Unit, Clinical Hospital University of São Paulo School of Medicine São Paulo Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2024 in Digestive Endoscopy
Verified
Journal Article
Closed access
MGMegui Marilia Mansilla Gallegos
Megui Marilia Mansilla Gallegos
IGIgor Logetto Caetité Gomes
Igor Logetto Caetité Gomes
VBVitor Ottoboni Brunaldi
Vitor Ottoboni Brunaldi
ABAlexandre Moraes Bestetti
Alexandre Moraes Bestetti
SMSergio Barbosa Marques
Sergio Barbosa Marques
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura

30 March 2021 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
JGJohn Alexander Lata Guacho
John Alexander Lata Guacho
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura
IRIgor Braga Ribeiro
Igor Braga Ribeiro
BMBruna Furia Buzetti Hourneaux De Moura
Bruna Furia Buzetti Hourneaux De Moura
MGMegui Marilia Mansilla Gallegos
Megui Marilia Mansilla Gallegos
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura
Background/Aims: Carbon dioxide is increasingly used in insufflation during colonoscopy in adult patients; however, air insufflation remains the primary practice among pediatric gastroenterologists. This systematic review and meta-analysis aims to evaluate insufflation using CO2 versus air in colonoscopies in pediatric patients. Methods: Individualized search strategies were performed using MEDLINE, Cochrane Library, EMBASE, and LILACS databases following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and Cochrane working methodology. Randomized control trials (RCTs) were selected for the present meta-analysis. Pooled proportions were calculated for outcomes including procedure time and abdominal pain immediately and 24 hours post-procedure. Results: The initial search yielded 644 records, of which five RCTs with a total of 358 patients (CO2: n=178 versus air: n=180) were included in the final analysis. The procedure time was not different between the CO2 and air insufflation groups (mean difference, 10.84; 95% confidence interval [CI], -2.55 to 24.22; p=0.11). Abdominal pain immediately post-procedure was significantly lower in the CO2 group (risk difference [RD], -0.15; 95% CI; -0.26 to -0.03; p=0.01) while abdominal pain at 24 hours post-procedure was similar (RD, -0.05; 95% CI; -0.11 to 0.01; p=0.11). Conclusions: Based on this systematic review and meta-analysis of RCT data, CO2 insufflation reduced abdominal pain immediately following the procedure, while pain was similar at 24 hours post-procedure. These results su est that CO2 is a preferred insufflation technique when performing colonoscopy in pediatric patients.

17 June 2024 in Digestive Endoscopy
Verified
Journal Article
Closed access
PSPedro Henrique Veras Ayres da Silva
Pedro Henrique Veras Ayres da Silva
AKAngelo So Taa Kum
Angelo So Taa Kum
IGIgor Logetto Caetité Gomes
Igor Logetto Caetité Gomes
NMNelson Tomio Miyajima
Nelson Tomio Miyajima
ABAlexandre Moraes Bestetti
Alexandre Moraes Bestetti
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura

1 July 2024 in Crohn’s & Colitis 360
Verified
Journal Article
Open access
PDF file
HFHiram Menezes Nascimento Filho
Hiram Menezes Nascimento Filho
AKAngelo So Taa Kum
Angelo So Taa Kum
ABAlexandre Moraes Bestetti
Alexandre Moraes Bestetti
PSPedro Henrique Veras Ayres da Silva
Pedro Henrique Veras Ayres da Silva
MGMegui Marilia Mansilla Gallegos
Megui Marilia Mansilla Gallegos
EMEduardo Guimarães Hourneaux de Moura
Eduardo Guimarães Hourneaux de Moura
Background: Successful Crohn’s disease (CD) therapy relies on timely and precise management strategies. Endoscopic balloon dilation (EBD) has been applied as a first-line treatment for symptomatic CD-associated strictures due to its minimally invasive nature and the possibility of preserving intestinal length. Objective: The aim of the present study was to determine patient-related predictive factors associated with the need for surgery for CD-associated ileocolic strictures after technically successful EBD. Methods: All original studies published before December 2023 that reported the outcomes of patients treated with EBD for ileocolic strictures secondary to CD and described follow-up for at least 1 year were included. The difference in risk of needing surgery was calculated for 8 different patient characteristics (Sex, smoking habit, previous surgery, biologic therapy, steroids, immunosuppressors, nature of the stricture, and endoscopic disease activity). Results: There were significant differences in the risk of needing surgery after EBD among patients who underwent surgery and patients without a history of surgery (RD: −0.20 [−0.31, −0.08]), patients with endoscopic mucosal activity and patients in remission at the time of EBD (RD: 0.19 [0.04, 0.34]), patients using biologics at the time of EBD and patients not using biologics (RD: −0.09 [−0.16, −0.03]), and patients using steroids and those not using steroids at the time of EBD (RD: 0.16 [0.07, 0.26]). Conclusions: The use of biologics and endoscopic disease remission at the time of EBD were protective factors against the need for surgery. No previous surgery or use of steroids at the time of EBD was associated with the need for surgery during follow-up.